![1]()
News
No reduction in PE risk with vena cava filters after severe injury
July 9, 2019
MELBOURNE – “Given the cost and risks associated with a vena cava filter, our data suggest that there is no urgency to insert the filter in patients who can be treated with prophylactic anticoagulation within 7 days after injury,” the investigators wrote.
![1]()
News
Study: Most patients hospitalized with pneumonia receive excessive antibiotics
July 8, 2019
Odds of adverse events increased by 5% per excess day of antibiotic treatment.
News
Risk of cardiac events jumps after COPD exacerbation
July 2, 2019
Acute COPD exacerbations are associated with an increased risk of major adverse cardiac events in the 4 weeks after the exacerbation.
News
Evidence supports accuracy of COPD diagnosis tool
July 1, 2019
Large, longitudinal study in diverse COPD populations affirms accuracy of FEV1:FVC ratio
![1]()
News
Subset of patients benefits from in-hospital sleep apnea screening
June 26, 2019
SAN ANTONIO – Readmission rates can be reduced in hospitalized cardiac patients who use CPAP consistently.
![1]()
News
Medicare may best Medicare Advantage at reducing readmissions
June 25, 2019
Editorialists provide reasons to exercise caution when interpreting the results.
![1]()
News
Penicillin-susceptible Streptococcus pneumoniae most common cause of bacteremic CAP
June 24, 2019
Narrow-spectrum aminopenicillins should be used specifically to treat children hospitalized from suspected bacterial CAP.
![1]()
News
New single-dose influenza therapy effective among outpatients
June 24, 2019
Is baloxavir marboxil, a selective inhibitor of influenza cap-dependent endonuclease, a safe and effective treatment for acute uncomplicated influenza?
![1]()
News
Adjuvant corticosteroids in hospitalized patients with CAP
June 18, 2019
The benefit of adjuvant corticosteroids is most clear in hospitalized patients with severe CAP.
![1]()
News
Rivaroxaban tied to higher GI bleeding than other NOACs
June 17, 2019
SAN DIEGO – Real-world studies comparing the GI bleeding rates among different non–vitamin K anticoagulants have been limited.
